thalidomide has been researched along with Anterior Choroidal Artery Infarction in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This patient developed acute, multiple cerebral infarctions 5 months into the treatment with thalidomide." | 3.73 | Should we screen patients for inherited thrombophilia before starting thalidomide? ( El-Hajj, II; Harb, MI; Mahfouz, RA; Otrock, ZK; Sawaya, RA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyakkoku, K | 1 |
| Nakajima, Y | 1 |
| Izuta, H | 1 |
| Shimazawa, M | 1 |
| Yamamoto, T | 1 |
| Shibata, N | 1 |
| Hara, H | 1 |
| Otrock, ZK | 1 |
| Mahfouz, RA | 1 |
| El-Hajj, II | 1 |
| Harb, MI | 1 |
| Sawaya, RA | 1 |
| Wong, EH | 1 |
| Leung, TW | 1 |
| Wong, KS | 1 |
3 other studies available for thalidomide and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Blood Pressure; Cell Death; Cells, Cultu | 2009 |
Should we screen patients for inherited thrombophilia before starting thalidomide?
Topics: Administration, Oral; Aged; Antigens; Cerebral Infarction; Humans; Immunosuppressive Agents; Male; M | 2006 |
Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
Topics: Adult; Arthritis, Rheumatoid; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combin | 2007 |